News summary

Face-photo AI flags mortality risk in 43,000 patients with cancer

Source: Longevity Docs News • Published: 20 Oct 2026, 00:00

Summarized by Masters of Longevity from Longevity Docs News.

Face-photo AI research invites readers to a news article about using facial images to estimate mortality risk in cancer patients, examining study design, limitations, and implications for future noninvasive health monitoring.

Face-photo AI flags mortality risk in 43,000 patients with cancer
Key Takeaways
  • Across 43,000 radiotherapy patients the highest-risk face-age quartile had more than three times mortality versus the lowest quartile.
  • The model was trained on over 40 million faces and applied retrospectively to photographs collected under a waiver of consent.
  • Face-age discrimination was modest with a C-index of 0.57 and performance weakened in Black and Hispanic patients.
Read the full article at Longevity Docs News ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.